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Loss of TGF-1 Leads to Increased Neuronal
Cell Death and Microgliosis in Mouse Brain
initiate or resolve inflammation (Dennler et al., 2002;
Massague´ et al., 2000; Roberts and Sporn, 1996). Conse-
quently, disruption of TGF-s results in severe isoform-
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membrane serine/threonine kinase receptors. LigandUniversity of California, San Diego
binding results in receptor phosphorylation and recruit-La Jolla, California 92093
ment of Smad proteins, which translocate to the nucleus3 GRECC
where they associate with other transcription factors toVA Palo Alto Health Care System
regulate gene transcription (Dennler et al., 2002; Mas-Palo Alto, California 94304
sague´ et al., 2000). How exactly specificity of signaling
is achieved is still unknown, but temporal and spatial
regulation of TGF-gene expression, differential bindingSummary
affinity to its receptor, and an array of extracellular bind-
ing molecules for TGF-s and intracellular signaling mol-TGF-1 is a key regulator of diverse biological pro-
ecules participate in the integration of TGF- signalingcesses in many tissues and cell types, but its exact
and the generation of an appropriate biological re-function in the developing and adult mammalian CNS
sponse (Dennler et al., 2002; Massague´ et al., 2000).is still unknown. We report that lack of TGF-1 expres-
TGF-s are probably expressed in most cell types insion in neonatal Tgfb1/ mice results in a widespread
vivo, and at least in culture almost all cells can synthe-increase in degenerating neurons accompanied by re-
size the TGF-1 isoform (Roberts and Sporn, 1996). Theduced expression of synaptophysin and laminin and
TGF-1 promoter is activated by wounding, ischemia,a prominent microgliosis. Lack of TGF-1 also strongly
and cellular stress in general (Kim et al., 1990; Robertsreduces survival of primary neurons cultured from
and Sporn, 1996). Accordingly, TGF-1, which is nor-Tgfb1/ mice. TGF-1 deficiency in adult Tgfb1/
mally present at low levels in healthy adult CNS cells,mice results in increased neuronal susceptibility to
is rapidly upregulated after injury and induces expres-excitotoxic injury, whereas astroglial overexpression
sion of many injury response genes (Finch et al., 1993).of TGF-1 protects adult mice against neurodegenera-
Cerebral TGF-1 expression is also increased with agetion in acute, excitotoxic and chronic injury paradigms.
(Finch et al., 1993). The main sources of TGF-1 in theThis study reveals a nonredundant function for TGF-
injured brain are astrocytes and microglia (Finch et al.,1 in maintaining neuronal integrity and survival of
1993), but neurons can produce it as well (Flanders etCNS neurons and in regulating microglial activation.
al., 1998). TGF-2 and TGF-3 are regulated mainly byBecause individual TGF-1 expression levels in the
hormonal and developmental signals, and it has beenbrain vary considerably between humans, this finding
speculated that they have a role in CNS developmentcould have important implications for susceptibility to
(Flanders et al., 1998).neurodegeneration.
Numerous studies used cultured neurons to show a
protective effect of TGF-1 against various toxins andIntroduction
injurious agents (reviewed in Flanders et al., 1998; Un-
sicker and Krieglstein, 2002). Similar results were ob-
Transforming growth factor- (TGF-) superfamily
tained when TGF-s were delivered intracerebrally or
members, including TGF-s, bone morphogenic pro- using viral vectors into adult rodent brains after ischemic
teins (BMPs), activins, glial derived neurotrophic factor injury (Unsicker and Krieglstein, 2002). In contrast, in
(GDNF), and nodal, fulfill key functions during develop- vivo neutralization of TGF-s with antibodies during
ment and in maintaining tissue homeostasis (reviewed early CNS development prevented ontogenetic neuronal
in Dennler et al., 2002; Massague´ et al., 2000). In the death in the chick embryo cilliary ganglion and retina
CNS, BMPs control neuronal, astroglial, and oligoden- (Du¨nker et al., 2001; Krieglstein et al., 2000), indicating
droglial cell induction, neuronal cell-type specification, that TGF-s can also trigger neuronal cell death under
and patterning (reviewed in Ebendal et al., 1998; Mehler certain conditions. Other support for an important role
et al., 1997). In contrast, little is known about the role for TGF-s and the TGF- signaling pathway in neuronal
of TGF-s in the CNS. development and function comes from recent experi-
The TGF- subfamily includes three isoforms in mam- ments in Drosophila and Aplysia (Chin et al., 2002;
mals, TGF-1, 2, and 3. They act in a highly contextual Sweeney and Davis, 2002; Zhang et al., 1997). In Dro-
manner, and depending on cell type and environment, sophila, TGF- receptors and dSmad2 are required for
TGF-s may promote cell survival or induce apoptosis, neuronal remodeling (Zheng et al., 2003). Mutations in
stimulate cell proliferation or induce differentiation, and spinster, resulting in enhanced TGF- signaling, caused
synaptic overgrowth, which could be reverted by down-
regulation of TGF- signaling (Sweeney and Davis,*Correspondence: twc@stanford.edu
4 These authors contributed equally to this work. 2002). In Aplysia sensory neurons, TGF-1 induces
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phosphorylation and redistribution of the presynaptic
protein synapsin and modulates synaptic function (Chin
et al., 2002; Zhang et al., 1997). However, none of the
above studies could address whether TGF-1 is re-
quired for neuronal development and survival in the
mammalian CNS and how it exerts its actions.
Here we used mice deficient in TGF-1 and primary
neuronal cultures from these mice to study the role of
TGF-1 in mammalian CNS development and injury.
C57BL/6 mice lacking TGF-1 have defects in vasculo-
genesis and angiogenesis leading to early embryonic
lethality at E9.5 without overt defects in brain develop-
ment at this early stage (Dickson et al., 1995; Kulkarni
et al., 1993). However, the NIH genetic background res-
cues Tgfb1/ mice from embryonic lethality (Bonyadi
et al., 1997). These mice have no overt developmental
abnormalities but succumb to an autoimmune wasting
syndrome at 3–4 weeks of age (Bonyadi et al., 1997).
We found that unmanipulated neonatal Tgfb1/ mice
show increased numbers of apoptotic neurons, a reduc-
tion in neocortical presynaptic integrity, reduced ex- Figure 1. TGF-1 Overexpression in Astrocytes Protects Against
pression of the extracellular matrix protein laminin, and Injury-Induced Neurodegeneration
widespread microgliosis. Cultured primary neurons (A and B) TGF-1 overexpression in astrocytes of TGF-1 tg mice
lacking TGF-1 have reduced survival compared with significantly reduced the loss of MAP-2 immunoreactivity (A) and
calbindin-positive pyramidal cells (B) induced by KA in the neocor-wild-type controls. Heterozygous knockout (Tgfb1/)
tex. Sagittal brain sections of 2- to 4-month-old TGF-1 heterozy-mice, which have normal life spans, show increased
gous transgenic low (tg low) and medium (tg med) expressors andsusceptibility to excitotoxic injury and neurodegenera-
nontransgenic littermate control (nontg) mice injected with 25 mg/kg
tion, whereas transgenic overproduction of TGF-1 pre- KA (black bars) or PBS (white bars) were stained for MAP-2, and
vented degeneration after excitotoxic injury. We con- the percent immunoreactive area of the neuropil was determined
clude that TGF-1 has a nonredundant function in by confocal microscopy and computer-aided image analysis or im-
munolabeled for calbindin and the numbers of neurons weremaintaining neuronal integrity and survival of CNS neu-
counted. Values are mean  SEM, *p  0.05; n.s., not significant,rons and in regulating microglial activation.
Tukey-Kramer test, 4–5 mice per genotype and treatment.
(C and D) TGF-1 overexpression in astrocytes of Apoe/ mice
Results significantly reduced the loss of MAP-2 (C) and synaptophysin (D)
immunostaining in the neocortex as a result of the lack of apoE.
Sagittal brain sections of 9- to 10-month-old nontransgenic (nontg),Cerebral Overexpression of TGF-1 Protects
Apoe/, heterozygous TGF-1 transgenic medium expressor (tgAgainst Acute and Chronic Neuronal Injury
med), and TGF-1 tg med, Apoe/ mice were immunolabeled forTo determine whether increased production of endoge-
MAP-2 and synaptophysin, and relative expression of these proteins
nous bioactive TGF-1 from astrocytes could protect was quantified as described above. Values in TGF-1 nontg,
against acute neuronal injury, we used 2- to 4-month- Apoe/ mice (indicated by *) are significantly different from all other
old mice expressing TGF-1 under control of the glial groups in (C) and (D). Values are mean  SEM, *p  0.01, Tukey-
Kramer test, 4–5 mice per genotype.fibrillary acidic protein (GFAP) promoter 2-fold (low, line
T64) or 4-fold (medium, line T115) above endogenous
TGF-1 mRNA levels (Wyss-Coray et al., 1995, 2000).
Heterozygous TGF-1 transgenic mice and nontrans- age (Figure 1A). Overexpression at medium levels also
prevented the loss in calbindin immunoreactivity in pyra-genic littermate controls were injected intraperitoneally
with kainic acid (KA) in an experimental model of excito- midal cells in the neocortex (Figure 1B). Although not
significantly different from nontransgenic mice, theretoxic neuronal injury (Schauwecker and Steward, 1997).
Excitotoxicity has been postulated to be a major mecha- is a trend toward higher numbers of calbindin-positive
neurons in the noninjured TGF-1 low expresser micenism of neuronal degeneration in stroke, Alzheimer
disease (AD), and other neurodegenerative diseases (Figure 1B).
To determine the effect of TGF-1 on chronic neuronal(Rothman and Olney, 1995). The mice used here overex-
pressing TGF-1 at low levels did not develop signs injury, we crossed Apoe knockout mice (Apoe/), which
show an age-dependent loss of synaptophysin-positiveof hydrocephalus as reported for high expressor mice
(Wyss-Coray et al., 1995), and KA treatment did not presynaptic terminals and neuronal cytoskeletal abnor-
malities (Masliah et al., 1995), with TGF-1 mice (linecause overt changes in brain architecture (data not
shown). However, KA treatment resulted in a 24% loss T115). No overt morphological changes were observed
in any of the resulting offspring (data not shown). Asof MAP-2 immunoreactivity (Figure 1A) and a 60% loss
in the number of pyramidal cells expressing calbindin described previously (Masliah et al., 1995), 9- to 10-
month-old mice lacking Apoe expression showed a(Figure 1B) in the neocortex (this loss in calbindin immu-
noreactivity is not accompanied by cell death [data not roughly 30% loss in MAP-2 immunostaining and synap-
tophysin-positive terminals compared with wild-typeshown]). TGF-1 overexpression in astrocytes at low or
medium levels significantly reduced the dendritic dam- mice (Figures 1C and 1D). TGF-1 overexpression at
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Table 1. Genotype and Weight Distribution in TGF-1-Deficient and Wild-Type Mice
Tgfb1 Genotype / / /
Genotype frequency [% (n)]a P1 25.0 (15) 51.7 (31) 23.3 (14)
P21 29.5 (39) 46.2 (61) 17.4 (23)
adult 39.1 (182) 60.9 (283) N/Ab
Body weight [g (n)] P1 1.4  0.1 (3) 1.5  0.03 (10) 1.4  0.1 (7)c
P21 12.6  0.9 (14) 13.3  0.6 (21) 8.5  0.6 (13)d
adult 30.9  1.3 (14) 29.6  1.7 (12) N/Ab
Hemibrain weight [mg (n)] P1 58.5  4.8 (3) 50.3  4.6 (13) 44.4  2.7 (4)c
P21 224.4  7.4 (9) 229.9  4.6 (12) 197.8  16.4 (5)c
adult 239.1  4.2 (3) 223.6  11.8 (4) N/Ab
a Percentage of mice surviving up to indicated age. Adult, 2- to 4-month-old.
b No survivors at this age.
c Not significantly different from Tgfb1/.
d p  0.01, Tukey-Kramer test.
medium levels (line T115) largely prevented this loss in Tgfb1/ mice (Figure 2B), indicating that the NIH
mouse strain is relatively resistant to excitotoxic neu-(Figures 1C and 1D). TGF-1, Apoe/mice did not differ
from their nontransgenic littermates, suggesting that ronal damage.
Consistent with the activated caspase labeling, 5- tohigher levels of TGF-1 do not increase the number of
synaptophysin-positive synaptic connections and den- 6-month-old KA-injected Tgfb1/mice showed a 6-fold
increase in the number of cells displaying terminaldrites above normal levels and do not prevent normal
age-related decreases in these proteins. Taken to- deoxynucleotidyl transferase-mediated dUTP nick end
labeling (TUNEL) compared with Tgfb1/ littermategether, TGF-1 overexpression largely prevents the loss
of synaptic and/or dendritic markers as well as the re- controls. Due to great interindividual variability in the
Tgfb1/mice, this difference was not statistically signif-duction in neuronal calbindin expression after chronic
and/or acute injury. icant (26.33  8.59 versus 157.60  77.49; p  0.2,
Mann-Whitney U test, 5–6 mice per genotype). TUNEL
colocalized largely with the neuronal marker NeuN (Fig-TGF-1-Deficient Mice Have Increased
ure 2D), indicating that neurons undergo apoptoticSusceptibility to Kainic Acid-Induced
changes in KA-lesioned, TGF-1-deficient mice. Al-Neuronal Injury
though more cells were caspase positive than TUNELTo test whether TGF-1 is not only sufficient but also
positive, areas with staining for the two markers over-necessary to protect neurons against acute neuronal
lapped, and relative numbers of TUNEL- and caspase-injury, we injected 5- to 6-month-old mice lacking one
positive cells correlated positively across both geno-copy of the Tgfb1 gene (Tgfb1/) and wild-type
types (r  0.984, p  0.001, 5–6 mice per genotype).(Tgfb1/) mice with KA. On the NIH/Ola background,
This finding is consistent with the two markers repre-Tgfb1/ mice show no gross abnormalities (Bonyadi
senting two aspects of the same apoptotic events andet al., 1997) and have similar brain and body weights
TUNEL identifying more severely damaged neurons thancompared with Tgfb1/ mice (Table 1). At 3 weeks (Fig-
the caspase marker.ure 2A) or 10 months of age (data not shown), unmanipu-
lated Tgfb1/mice express approximately half the TGF-
1 mRNA compared with Tgfb1/ littermates. Tgfb1/ Unmanipulated Tgfb1/ Mice Display
Neuronal Degenerationmice express no TGF-1 mRNA (Figure 2A). Levels of
TGF-2 mRNA in the brain were also not significantly To test whether lack of TGF-1 expression further in-
creases susceptibility to neuronal cell death and degen-different between 10-month-old Tgfb1/ and Tgfb1/
littermate controls (6.4  1.6 versus 7.2  1.5; p  0.7; eration, 1-day-old (P1) or 21-day-old (P21) Tgfb1/mice
were analyzed and compared with Tgfb1/ andn  10 mice per genotype). Others have reported that
TGF-2 and TGF-3 mRNAs are not altered in heart or Tgfb1/ littermate controls. Tgfb1/ breedings re-
sulted in the expected frequency of Tgfb1/mice (Tablelung of Tgfb1/ mice (Kulkarni et al., 1993).
Twenty-four hours after KA injection, 5- to 6-month- 1) on the NIH/Ola background (Bonyadi et al., 1997).
Body and brain weights were normal at P1, but Tgfb1/old Tgfb1/ mice expressing reduced levels of endoge-
nous TGF-1 showed a 17-fold increase in the number mice weighed around 30% less than Tgfb1/ and
Tgfb1/ littermates at 3 weeks of age (Table 1), as aof caspase-positive cells compared with Tgfb1/ lit-
termate controls (Figure 2B). All mice seized similarly result of the peripheral wasting syndrome in these mice
(Geiser et al., 1993; Kulkarni et al., 1993; Shull et al.,and reached a minimum of stage 3 on a 0 to 5 seizure
scale (see Experimental Procedures; data not shown), 1992). Brains of Tgfb1/mice at all ages had a tendency
to weigh less than those of control littermates, althoughsuggesting that this increase was not caused by differ-
ences in drug kinetics or availability in the two geno- this did not reach statistical significance (Table 1). Neo-
cortices of P21 Tgfb1/ mice appeared compacted andtypes. The vast majority of caspase-positive cells were
neurons (Figure 2C). They were observed in the neocor- thinner than Tgfb1/ cortices on histological sections
(Figure 3), but staining with H&E, cresyl violet (Figurestex, hippocampus, caudate, putamen, amygdala, and
thalamus. Only few caspase-positive cells were found 3A and 3B), or NeuN (data not shown) showed no gross
Neuron
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Figure 2. Tgfb1/ Mice Display More
Caspase- and TUNEL-Positive Neurons than
Tgfb1/ Mice following Excitotoxic Injury
(A) Cerebral TGF-1 mRNA levels in unmani-
pulated P21 Tgfb1/, Tgfb1/, and Tgfb1/
mice as determined by RNase protection
assay. Specific signals were quantified and
normalized to -actin mRNA as a control. Val-
ues are mean  SEM, *p  0.01, Tukey-
Kramer test, 3–4 mice per genotype.
(B) Coronal brain sections of 5- to 6-month-
old Tgfb1/ and Tgfb1/ mice injected with
15 mg/kg KA were labeled with a FITC-tagged
panspecific inhibitor of activated caspases,
and the number of positive cells per section
was counted. Values are mean  SEM, *p 
0.009, Mann-Whitney U test, 5–6 mice per ge-
notype.
(C and D) Double labeling and confocal mi-
croscopy of coronal brain sections from KA-
injected Tgfb1/ mice identified most cells
positive for activated caspases (C) or TUNEL
(D) as neurons using the neuronal nuclear
protein NeuN. Representative cortical areas
are shown. Scale bar, 200 m (C) and 30
m (D).
abnormalities in brain architecture. Consistent with the not observed at P21 or in Tgfb1/ and Tgfb1/ mice
(data not shown).reported effects of TGF-1 on blood vessel formation
(Dickson et al., 1995), Tgfb1/ mice showed abnormally To determine whether loss of TGF-1 results in in-
creased neuronal cell death or degeneration, brain sec-distended cortical blood vessels at P1, but they were
Figure 3. Tgfb1/ Mice Show No Gross Structural Abnormalities in the Brain
(A and B) Sagittal brain sections of unmanipulated P21 Tgfb1/, Tgfb1/, and Tgfb1/ mice were stained with eosin & hematoxylin (A) or
cresyl violet (B). While no apparent damage could be observed, the neocortex of Tgfb1/ mice seemed thinner and condensed (A and B).
(C) Immunolabeling for PCNA revealed no obvious differences in cell proliferation, as illustrated here in the dentate gyrus. Scale bar, 250 m
(A and B) and 50 m (C).
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Figure 4. Absence of TGF-1 Results in Neu-
ronal Damage and Reduced Synaptic Density
(A) Sagittal brain sections of P1 and P21 un-
manipulated Tgfb1/, Tgfb1/, and Tgfb1/
mice labeled for TUNEL showed an increase
in the number of positive cells per area in
the neocortex of Tgfb1/ mice. Values are
means SEM, *p 0.05, Tukey-Kramer test,
3–5 mice per genotype.
(B–D) Double labeling and confocal micro-
scopy of coronal brain sections from P1
Tgfb1/ mice identified most TUNEL-posi-
tive cells as neurons using green fluorescent
Nissl labeling with TUNEL in red (B and C)
or using neurofilament immunolabeling in red
with TUNEL in green (D).
(E and F) Coronal brain sections of unmanipu-
lated P21 Tgfb1/ (E) and Tgfb1/ (F) mice
were immunolabeled for activated caspase
3. Positive neurons in the neocortex with long
processes (arrowheads) were only observed
in Tgfb1/ mice. Arrows point to condensed
nuclei or nonneuronal caspase 3-positive cells.
(G and H) Sagittal brain sections of unmanipu-
lated P21 Tgfb1/, Tgfb1/, and Tgfb1/
mice were immunolabeled for synaptophysin,
the percent immunoreactive area of the neu-
ropil was determined by confocal microscopy
and computer-aided image analysis (G) and
correlated with relative TGF-1 mRNA levels
measured in opposite hemibrains (H). Each
symbol represents one mouse. Values are
meansSEM, **p 0.05, Tukey-Kramer test,
3–8 mice per genotype.
Scale bar, 200 m (C), 20 m (D), and 120
m (F).
tions from Tgfb1/, Tgfb1/, and Tgfb1/ littermates Tgfb1/ mice and Tgfb1/ littermate controls, indicat-
ing no gross abnormalities in neuronal maturation andwere analyzed by TUNEL and synaptophysin staining.
P1 Tgfb1/ mice showed prominent TUNEL staining cellular proliferation. Besides the increase in TUNEL-
positive neurons, unmanipulated 3-week-old Tgfb1/in different parts of the brain, including the neocortex
(Figures 4B and 4C), caudate putamen, and cerebellum. mice showed also significantly less synaptophysin-posi-
tive synapses in the neocortex (Figure 4G) and hippo-In the neocortex, Tgfb1/ mice had significantly more
TUNEL-positive cells than Tgfb1/ littermates at P1 and campus (data not shown) compared to Tgfb1/ and
Tgfb1/ littermate controls, and relative levels of cere-P21 (Figures 4A–4C). Some TUNEL-positive cells were
also observed in Tgfb1/ mice, which is consistent with bral TGF-1 mRNA correlated positively with the area
of the cortex occupied by synaptophysin-positive pre-neuronal cell death due to active neurogenesis during
the first postnatal week in mice (Johnson and Deck- synaptic terminals (Figure 4H). This reduction in synap-
tophysin immunoreactivity was not restricted to the NIHwerth, 1993). Tgfb1/ mice had a trend toward in-
creased numbers of TUNEL-positive neurons at P1 but genetic background. Tgfb1/ mice (12- to 14-months-
old) on the C57BL/6 background had significantly lessnot P21 (Figure 4A). Most of the TUNEL-positive cells
were identified as neurons by colocalization with fluo- synaptophysin immunostaining in the neocortex than
wild-type littermate controls (23.9  0.5 versus 26.4 rescent Nissl stain (Figures 4B and 4C) or by colocaliza-
tion of TUNEL and neurofilament immunostaining and 0.4; p  0.005, Student’s t test, 8 mice per genotype),
consistent with synaptic/neuronal degeneration as a re-analysis by laser scanning confocal microscopy (Figure
4D). Furthermore, immunostaining with an antibody sult of reduced TGF-1 expression.
against activated caspase 3 labeled neurons with long
processes in P21 Tgfb1/ but not Tgfb1/ littermates Lack of TGF-1 Expression Results in Changes
in Extracellular Matrix Expression in the Brain(Figures 4E and 4F). To determine whether the increase
in TUNEL-positive neurons was the result of increased TGF-1 is an important regulator of extracellular matrix
synthesis (McCartney-Francis and Wahl, 1994), and weproliferation or delayed maturation of neuronal precur-
sors, we stained brain sections with doublecortin (data have previously shown that overproduction of TGF-1
in astrocytes of transgenic mice results in increasednot shown), a marker of immature neurons (Gleeson et
al., 1998), or PCNA, a nuclear proliferation marker (Figure production of laminin and fibronectin (Wyss-Coray et
al., 1995). Laminin in particular has been implicated in3C). No obvious differences in staining intensities or
distribution of these markers were observed between CNS development, neuronal survival, and learning and
Neuron
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Figure 5. Lack of TGF-1 Results in De-
creased Expression of Laminin in the CNS
(A and B) Sagittal brain sections of unmanipu-
lated P21 Tgfb1/ and Tgfb1/ mice labeled
with a panspecific antibody against laminin.
Note the decrease in staining in neocortical
layers II and III as well as in blood vessels
(arrows) in Tgfb1/ compared with Tgfb1/
mice (A). Quantitative analysis of laminin im-
munostaining in layers II/III in four fields per
section and three sections per mouse (B)
showed that several Tgfb1/ mice ex-
pressed clearly less laminin, although vari-
ability is considerable. Each symbol repre-
sents one mouse. Scale bar, 150 m (A).
(C and D) Western blots of hippocampi and
cortices from 1- to 3-day-old Tgfb1/ (white
bars) and Tgfb1/ mice (black bars) probed
with a panspecific antibody against laminin
or antibodies against the 1 chain (Lam-1)
or 1 chain (Lam-1) (C). 	, , and  labels indicate the approximate size of the three laminin chains. Signal intensities were quantified (D)
and normalized against actin signals. Values are means  SEM, *p  0.05, Student’s t test, 4–5 mice per genotype.
memory (Luckenbill-Edds, 1997; Venstrom and Rei- consistently result in prominent gene activation and
were shown to be optimal to promote survival of wild-chardt, 1993), and it is conceivable that TGF-1-depen-
dent changes in extracellular matrix expression may type neurons in culture (Chalazonitis et al., 1992). In our
hands, recombinant TGF-1 did not increase survival ofunderlie at least some of the degenerative changes ob-
served in TGF-1-deficient mice. Indeed, laminin ex- wild-type neurons, which may be due to the type
of neurons and the culture conditions used (e.g., addi-pression was reduced in Tgfb1/ mice compared with
control littermates (Figure 5). Immunostaining with a tion of B27 supplement). Similarly, culturing primary
Tgfb1/ or Tgfb1/ neurons with primary astrocytespanspecific laminin antibody was consistently weaker in
medium-size blood vessels of 3-week-old mice lacking from Tgfb1/ or Tgfb1/ mice failed to increase sur-
vival in a TGF-1-dependent way (Figure 6C). In con-TGF-1 (Figure 5A). In addition, there was a 40% reduc-
tion in laminin immunoreactivity in neocortical layers II trast, survival of both wild-type and Tgfb1/ neurons
is significantly increased by astrocyte-derived factorsand III, although this did not reach significance due to
the heterogeneity among Tgfb1/ mice (Figures 5A and independent of the TGF-1 genotype. This failure of
exogenous TGF-1 to increase cell survival in Tgfb1/5B). Using the same panspecific antibody, laminin pro-
tein expression was significantly reduced by Western neurons could have several reasons, including a perma-
nent defect in these cells as a result of TGF-1 deficiencyblot in hippocampi and cortices from 1- to 3-day-old
Tgfb1/ mice. Laminins are heterotrimeric proteins during development, a requirement for autocrine TGF-
1 signaling, or a requirement for TGF-1 release andcomposed of an 	, , and  chain (Luckenbill-Edds,
1997). Each chain exists in different isoforms, forming signaling at synapses (Chin et al., 2002; Zhang et al.,
1997).at least 12 different laminins. In Tgfb1/ mice, the lami-
nin 1 chain was reduced in addition to total laminin,
whereas laminin 1 levels were unchanged (Figures 5C Prominent Microgliosis in Tgfb1/ Mice Does Not
and 5D). These results indicate that TGF-1 is necessary Involve Specific Immune-Mediated Mechanisms
for normal laminin expression in the CNS. We observed that brain regions with caspase- or TU-
NEL-positive neurons in KA-injected Tgfb1/ adult
mice contained F4/80-positive activated microglia (Fig-Primary Neurons from TGF-1-Deficient Mice
Show Reduced Survival that Is Not Rescued ures 7C and 7D), indicating an inflammatory response
in areas of degenerating neurons. KA-injected adultby Exogenous Sources of TGF-1
Primary hippocampal/cortical neurons from Tgfb1/ Tgfb1/ mice on the NIH background, which showed
no or very few caspase-positive cells (Figures 2B andmice showed reduced neuronal cell numbers after 5 and
11 days in culture compared to primary neurons from 7A), did not display F4/80-positive activated microglia
(Figure 7B).Tgfb1/ mice (Figures 6A and 6B), consistent with the
observations in Tgfb1/ mice. Neurons from Tgfb1/ Microgliosis was even more prominent in mice com-
pletely lacking TGF-1. Unmanipulated Tgfb1/ micemice showed intermediate survival. In contrast, glial cell
numbers, which made up around 5% of cultured cells, showed a striking microgliosis in the neocortex and hip-
pocampus at P1 and even more so at P21 (Figures 7Fwere not significantly different in cultures from Tgfb1/
and Tgfb1/ mice (Figure 6B). Interestingly, addition of and 7H). At P21, TGF-1 expression in Tgfb1/ mice
was sufficient to prevent microgliosis, and the area ofrecombinant TGF-1, both bioactive peptide or the la-
tent form, which consists of active peptide plus propep- F4/80-positive cells in the cortex was not significantly
different from Tgfb1/ mice (Figure 7H). Interestingly,tide (Munger et al., 1997), failed to increase survival
of Tgfb1/ neurons (Figure 6C) at concentrations that no concomitant increase in astrocyte activation was ob-
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thus, lacking functional B and T lymphocytes showed
a similar intensity and pattern of TUNEL staining (Figures
7P and 7Q) and microglial activation (Figures 7F and 7G)
as immunocompetent Tgfb1/, Rag1/ mice. Whereas
peripheral tissues including heart (Figure 7M), lung, and
liver (data not shown) were severely inflamed in Tgfb1/
mice, no lymphocyte and CD4 cell infiltration was de-
tected in the heart (Figure 7L), brain, or other peripheral
organs (data not shown) of a Tgfb1/, Rag1/
mouse. Therefore, neurodegeneration and microgliosis
in Tgfb1/ mice appear to be independent of lympho-
cyte-mediated effects.
Discussion
The use of mice lacking or overexpressing TGF-1 in
the CNS has allowed us to demonstrate that this growth
factor plays a critical role in maintaining neuronal integ-
rity and survival and in regulating microglial activation.
At least some of these effects may be the result of
reduced extracellular matrix production. Despite their
sharing of the same receptor with TGF-1, the isoforms
TGF-2 and TGF-3 could not substitute for deficiency
in TGF-1 expression.
The current results are consistent with TGF-1 in-
creasing the probability of neuronal survival rather than
being an absolute requirement for survival. During post-
natal development, loss of TGF-1 increases neuronal
cell death most prominently at P1 when neurogenesis
Figure 6. TGF-1-Deficient Primary Neurons Show Reduced Sur- is highest, and this is still ongoing at high levels in P21
vival in Culture Tgfb1/ mice but not in wild-type littermates (Figure 4).
(A) Representative examples of Tgfb1/ and Tgfb1/ primary neu- Consistent with these findings, primary neurons lacking
rons stained for F-actin with BODIPY-FL-Fallacidin (green) and for
TGF-1 showed reduced survival in culture comparedDNA with Hoechst (blue) after 11 days in culture.
with wild-type controls (Figure 6). In addition, TGF-1(B) Primary neuronal cultures were stained as above at the indicated
deficiency in adult Tgfb1/ mice does not result in overttime points, and the number of viable neurons per mm2 was counted
based on the absence of pyknotic nuclei. Tgfb1/ cultures had neurodegeneration but increases neuronal cell loss after
significantly fewer viable neurons than Tgfb1/ controls (*p 0.05, excitotoxic injury (Figure 2) and promotes age-related
Tukey Kramer; **p  0.005, Student’s t test), but the number of glial loss of synaptophysin immunoreactivity (see Results).
cells was not different (Student’s t test). Each symbol represents
At P21, unmanipulated Tgfb1/ mice exhibit reducedthe mean value from three individual cultures and eight to nine fields
synaptic density compared to Tgfb1/ littermate con-per culture established from one mouse. Note the different scale
trols, and the loss of synaptophysin immunoreactivityfor neurons and glial cells.
(C) Exogenous recombinant human TGF-1 (rTGF-1; 1 ng/ml or as in P21 mice of all genotypes correlates inversely with the
indicated) or recombinant human latent TGF-1 (rLTGF-1; 1 ng/ml) amount of TGF-1 mRNA expression in the neocortex
could not rescue neuron survival in Tgfb1/ cultures. Cell numbers (Figure 4). Together, these results demonstrate that
were counted as above after 5 days in culture. Neurons were also
TGF-1 is a survival factor for mouse CNS neurons incocultured with wild-type or Tgfb1/ primary astrocytes (astro) in
vivo and in cell culture.transwell plates. Values are means  SEM, *p  0.05 compared
Interestingly, exogenous TGF-1 was not able to pre-with controls for the same genotype, Tukey-Kramer test, 3–4 mice
per genotype. vent the accelerated cell death in cultured Tgfb1/ neu-
rons. Thus, addition of recombinant TGF-1 at high con-
centrations or coculture with primary astrocytes failed
to increase survival of cultured Tgfb1/ neurons in aserved in Tgfb1/ compared with Tgfb1/ mice (Fig-
ures 7N and 7O). Because Tgfb1/ mice succumb to a TGF-1-dependent way (Figure 6). In contrast, astroglial
overproduction of TGF-1 in wild-type mice is sufficientlethal systemic autoinflammation characterized by infil-
tration of CD4-positive lymphocytes into various periph- to increase the survival of neurons to acute and chronic
injury (Figure 1). Thus, the lack of TGF-1 during earlyeral organs at the time of weaning around 3 weeks of
age (Geiser et al., 1993; Kulkarni et al., 1993; Shull et development cannot be fully compensated for by sup-
plying TGF-1 in culture, but astroglial-derived TGF-1al., 1992) (Figure 7M), it was possible that the micro-
gliosis and neurodegeneration we observed were the is sufficient to increase neuronal survival after injury in
the adult brain of wild-type mice. Alternatively, neuronsresult of a specific immune reaction in the brain. How-
ever, we found, on average, less than ten CD4-positive may need to produce their own TGF-1 in an autocrine
fashion to overcome the lack of TGF-1 during develop-lymphocytes per brain section in P21 Tgfb1/ mice
(Figure 7K). More importantly, Tgfb1/ mice deficient ment. Such a critical action of TGF-s in neuronal devel-
opment is supported by a recent study using rat mes-in the recombination associated gene (Rag1/) and,
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Figure 7. Microglial Activation and Neuronal Cell Death in Tgfb1/ Mice Is Independent of Specific Immune Mechanisms
(A–D) Caspase-positive cortical cells in KA-injected adult Tgfb1/ mice are associated with microglial activation. Adjacent coronal cortical
brain sections were labeled for activated caspases (A and C) or immunolabeled for the microglial marker F4/80 (B and D).
(E–G) F4/80 immunolabeling shows extensive microgliosis in P21 Tgfb1/ mice (F) that was independent of specific immune responses as
demonstrated in lymphocyte-deficient Tgfb1/, Rag1/ mice (G).
(H) The percent neocortical area occupied by F4/80-positive microglia was significantly larger in Tgfb1/ than in Tgfb1/ or Tgfb1/ littermate
control mice at P1 and P21. Values are mean  SEM, *p  0.01, Tukey-Kramer test, 3–5 mice per genotype.
(I–K) Very few CD4-positive lymphocytes (arrows in [K]) were detected in brain sections of Tgfb1/ mice immunolabeled for CD4 at P21. A
mouse with EAE (J), which served as a positive control, showed extensive infiltration of CD4 cells into the periventricular region.
(L and M) Extensive CD4 cell infiltration in the heart of a P21 Tgfb1/, Rag1/ mouse (M), whereas a lymphocyte-deficient Tgfb1/, Rag1/
heart has no infiltrates (L).
(N and O) GFAP immunostaining was not altered by lack of TGF-1 at P21.
(P and Q) Lymphocyte-deficient Tgfb1/, Rag1/ mice (P) show similar numbers and pattern of TUNEL-positive cells as Tgfb1/, Rag1/
mice (Q).
Scale bars, 50 m (A–D, P, and Q), 750 m (E–G, N, and O), and 100 m (I, K, L, and M).
encephalic cultures and chick embryos to show a to rescue Tgfb1/ embryos from lethality (Chagraoui et
al., 2001). Last, TGF-1 may have to be produced andrequirement for TGF-s in the development and survival
of dopaminergic neurons (Farkas et al., 2003). Interest- released at the synapse to increase survival of Tgfb1/
neurons or rescue the loss in synaptic density in TGF-ingly, similar developmental mechanisms may be at play
in peripheral organs. Transgenic overproduction of 1-deficient mice. This possibility is supported by recent
studies implicating TGF-1 or the TGF- signaling path-TGF-1 from the liver could not overcome the lethal
phenotype of Tgfb1/ mice, despite restoration of se- way in synaptic growth and function in Aplysia (Chin et
al., 2002; Zhang et al., 1997) and Drosophila (Sweeneyrum TGF-1 to wild-type levels (Longenecker et al.,
2002), and adenoviral overproduction of TGF-1 in preg- and Davis, 2002; Zheng et al., 2003). Studies using con-
ditional gene knockout strategies to interfere with neu-nant Tgfb1/mice, and consequently in embryos, failed
Neurodegeneration in TGF-1-Deficient Mice
1141
ronal TGF- signaling in adult mice could help in as- tective effects (Sometani et al., 2001). Thus, it is conceiv-
able that a deficiency in TrkB-dependent neurotrophinsessing the importance of TGF- signaling in synaptic
growth and function in the mammalian CNS. signaling contributes to the neuronal defects observed
in Tgfb1/ mice.Different mechanisms have been postulated to ex-
plain how TGF-1 protects neurons against injury and Whether and how the effects of TGF-1 deficiency on
neurons relate to the microgliosis in Tgfb1/ is unclear.degeneration (Flanders et al., 1998), and because neu-
rons as well as glial cells can express TGF- receptors TGF-1 is a key regulator of specific and innate immune
functions (Dennler et al., 2002; Letterio and Roberts,(Flanders et al., 1998), neuronal protection could be di-
rect or indirect. Our studies here show that TGF-1 defi- 1997, 1998). It can suppress specific immune responses
by inhibiting T lymphocyte proliferation and maturationciency results in abnormal expression and reduction of
the extracellular matrix protein laminin, which might be or by inducing apoptosis (Letterio and Roberts, 1998),
and it reduces MHC class II expression (Letterio andresponsible, at least in part, for the reduced survival and
increased susceptibility of neurons to injury. Laminin Roberts, 1998). Genetic studies indicate that uncon-
trolled MHC class II expression is the cause of lympho-has been implicated in CNS development, neuronal sur-
vival, and learning and memory (Luckenbill-Edds, 1997; cyte-mediated autoimmune reactions and the wasting
syndrome in Tgfb1/ mice (Diebold et al., 1995; GeiserVenstrom and Reichardt, 1993). TGF-1 is a known in-
ducer of laminin synthesis in cultured cells and in the et al., 1993; Letterio et al., 1996). Our studies with
Rag1/ mice, which lack mature T and B lymphocytesCNS of transgenic mice (Wyss-Coray et al., 1995), and
the current results indicate that TGF-1 is also required and fail to mount an antigen-specific immune response
(Mombaerts et al., 1992), demonstrate that the accumu-for normal expression of laminin in the brain (Figure 5).
In addition, degradation of laminin, specifically laminin lation of apoptotic neurons and neuroinflammation are
not caused by these immune cells (Figure 7).10 (Indyk et al., 2003), by tissue plasminogen activator
(tPA) and/or plasmin has been proposed to be responsi- However, besides these effects on specific immune
mechanisms, TGF-1 regulates innate immune func-ble for neuronal cell death associated with KA-induced
excitotoxicity (Chen and Strickland, 1997). This degra- tions, including the differentiation and proliferation of
macrophages (Letterio et al., 1996), which are closelydation is presumed to eliminate the critical surface for
support of neuronal function and survival (Luckenbill- related to microglia. In this role, TGF-1 has been shown
to facilitate effective corpse clearance or phagocytosisEdds, 1997; Venstrom and Reichardt, 1993). Because
TGF-1 is a key inducer of plasminogen activator inhibi- of apoptotic cells by macrophages and other cells (Fa-
dok et al., 1998, 2000; Freire-de-Lima et al., 2000), and ittor (PAI) 1 (Loskutoff et al., 1989), which is probably the
main inhibitor of tPA (Loskutoff et al., 1989) and thus promotes the clearance of amyloid peptides by cultured
microglia (Wyss-Coray et al., 2001). Hence, mice lackingthe above KA-mediated cascade (Tsirka et al., 1996),
neuronal survival in Tgfb1/ mice may be reduced due TGF-1 may be less efficient in the clearance of ran-
domly dying cells or in suppressing inflammation aroundto accelerated degradation of laminin.
TGF-1 may also promote neuronal survival by inter- active phagocytes. Interestingly, cells undergoing cell
death have been shown to secrete TGF-1, possibly toacting with neurotrophins. Although it is considered not
to be a prototypic neurotrophic factor for purified neu- reduce local inflammation and prevent degeneration of
additional surrounding cells (Chen et al., 2001). Althoughrons (Chalazonitis et al., 1992; Unsicker and Krieglstein,
2000, 2002), TGF-1 has been shown to synergize with our study cannot establish a cause-effect relationship
between microgliosis and apoptotic changes in neu-neurotrophins or to be required to mediate at least some
of the effects of NGF, BDNF, NT-3, and NT4 (reviewed rons, it is intriguing that microgliosis is absent in adult
Tgfb1/ mice, but activated microglia are closely asso-in Unsicker and Krieglstein, 2000, 2002) as well as FGF-2
(Krieglstein et al., 1998) and GDNF (Schober et al., 1999). ciated with apoptotic neurons in the same mice after
injury (Figure 7). Similarly, P1 Tgfb1/ mice showedInterestingly, deficiency in most of these classical neuro-
trophic factors did not result in overt neurodegeneration apoptotic cells surrounded by activated microglia in var-
ious brain regions. Therefore, it could be argued thatin the CNS of mutant mice (Huang and Reichardt, 2001).
However, neurotrophin receptor TrkB-deficient mice neurons and other cells exposed to proapoptotic signals
or normal stress may be cleared less efficiently by micro-showed an increase in postnatal apoptosis of CNS neu-
rons and increased susceptibility to injury (Alcantara et glia in TGF-1-deficient mice, thus contributing to
“spreading” of cell death or degeneration and inflamma-al., 1997; Minichiello and Klein, 1996), and postnatal
deletion of the trkB gene in pyramidal neurons resulted tion from focal points of injury.
Our results show that TGF-1 has a nonredundantin progressive loss of dendritic arborization and cortical
neurodegeneration in mice (Xu et al., 2000). Deficiency function in supporting neuronal survival and integrity
and in regulating microglial activation. Lack of TGF-1of the TrkB ligand BDNF resulted in a prominent reduc-
tion of calbindin and parvalbumin expression (Jones et exacerbates neuronal injury during development or after
excitotoxic lesions, possibly due to reduced trophical., 1994), and mice lacking TrkB and TrkC receptors
show massive cell death of hippocampal and cerebellar support and impaired microglial responses. It is impor-
tant to note that genetic polymorphisms in the humangranule cells (Minichiello and Klein, 1996). The pheno-
type observed in the current study appears somewhat TGFB1 gene are associated with different levels of
TGF-1 in the serum (Grainger et al., 1999) and possiblysimilar to the one associated with TrkB signaling defi-
ciency in TrkB knockout mice. Interestingly, treatment in other tissues as well. Interestingly, increased cerebral
TGF-1 production reduced -amyloid accumulation inof primary rat cortical neurons with TGF-1 increased
the expression of TrkB and its ligand BDNF, whereas the brain parenchyma of mice that model AD (Wyss-
Coray et al., 2001), and cortical TGF-1 mRNA levels inblocking TrkB signaling abolished TGF-1’s neuropro-
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counterstained with eosin-phloxine solution (Sigma) for 2 min, dehy-human AD cases correlated inversely with the extent of
drated, and mounted. For cresyl violet staining, sections were depar--amyloid deposition in the midfrontal cortex (Wyss-
affinized, washed in PBS, stained in 0.02% cresyl violet (Sigma) inCoray et al., 2001). Conceivably, individuals with lower
acetate buffer for 40 min, washed in 95% ethanol plus acetic acid,
levels of TGF-1 production may be more susceptible dehydrated, and mounted.
to amyloidosis and neurodegeneration.
Immunohistochemistry
Sections were pretreated for 20 min in Tris-buffered saline withExperimental Procedures
0.05% Tween 20 (TBST) with 0.1% Triton X-100 and 0.3% H2O2
(Sigma) to maximize antigen exposure and quench endogenousMice
peroxidase activity, respectively. Cryosections were fixed in 4%TGF-1 transgenic mice expressing porcine TGF-1 under control
PFA for 20 min or in acetone for 4 min (for CD4 and F4/80 labeling).of the glial fibrillary acidic protein (GFAP) promoter in astrocytes at
To block nonspecific interactions, all sections were incubated forlow or medium levels (Wyss-Coray et al., 1995, 2000) were used on
5–7 min in Superblock (Scytek) or for 1 hr in 10% serum (Vector) ofthe C57BL/6J genetic background. All transgenic mice used in the
the species in which the secondary antibody was raised. Sectionsstudy were heterozygous for the TGF-1 transgenes. Apoe/ mice
were then incubated with primary antibodies against MAP-2 (Roche,(C57BL/6J-Apoetm1Unc) were obtained from the Jackson Laboratory
dilution 1:1000), synaptophysin (Roche, 1:800), calbindin (Sigma,(Bar Harbor, ME). Mice lacking one (Tgfb1/) or both (Tgfb1/)
1:2500), neuronal nuclear protein (NeuN; Chemicon, 1:1000), thecopies of the Tgfb1 gene have been described (Bonyadi et al., 1997)
neuronal differentiation and migration marker doublecortin (Chemi-and were obtained from Dr. R. Akhurst (University of California, San
con, 1:15,000), proliferating cell nuclear antigen (PCNA; DAKO,Francisco). On the NIH/Ola background, Tgfb1/ mice show no
1:1500), neurofilament (Sternberger Monoclonals, 1:5000), cleavedgross abnormalities, and more than 80% of Tgfb1/ conceptuses
caspase 3 (Cell Signaling, 1:1500), laminin (Sigma, 1:100), the macro-reach parturition. However, Tgfb1/ mice die shortly after 3 weeks
phage/microglial marker F4/80 (Serotec, 1:100), the astrocyticof age of a severe multifocal autoinflammatory disorder (Shull et al.,
marker GFAP (DAKO, 1:1000), or the helper T cell marker CD4 (BD1992) and, as a result, were obtained via Tgfb1/ 
 Tgfb1/
Pharmingen, 1:60) at 4C overnight.crosses. Tgfb1/ mice on the C57BL/6J genetic background (Shull
For light microscopy, sections were incubated with a biotinylatedet al., 1992) were obtained from Jackson Laboratories. Rag1/mice
secondary antibody (Vector; 1:200) for 1 hr and developed with(Balb/c background) were obtained from Dr. R. Locksley (University
diaminobenzidine and H2O2 (Sigma) using the ABC Elite kit (Vector).of California, San Francisco) and crossed with Tgfb1/ mice for
For fluorescence microscopy, sections were incubated with fluores-two generations. Only 2 out of 64 mice (expected frequency 16 out
cein isothiocyanate- (FITC) or Cy5-conjugated secondary antibodiesof 64) were born from crossing Tgfb1/, Rag1/ with Tgfb1/,
(Vector or Jackson Immunoresearch, respectively, 1:200) for 1 hr,Rag1/mice. This lethality was most likely due to the Balb/c genetic
mounted with Vectashield (Vector), and viewed with a Radiancebackground of the Rag1/ breeders which is associated with em-
2000 laser scanning confocal system (Bio-Rad) mounted on an
bryonic lethality in Tgfb1/ mice. Brain tissue from a mouse with
Olympus BX-60 microscope.
severe experimental autoimmune encephalomyelitis (EAE) was
MAP-2 and synaptophysin are reliable indicators of, respectively,
kindly provided by Dr. E. Foehr (Gladstone Institutes, San Francisco). synaptic and dendritic damage and have been demonstrated to
Mice were genotyped by subjecting proteinase K-digested tail tissue correlate well with loss of cognitive function in murine models of
to touchdown PCR (Hecker and Roux, 1996) and were kept under neurodegeneration and humans with AD (Buttini et al., 1998; Terry
a 12 hr light/dark cycle with free access to sterile water and food et al., 1991). The percent area of neuropil occupied by MAP-2-
(Picolab Rodent Diet 20, #5053, PMI Nutrition International). Animal immunoreactive processes and synaptophysin-immunoreactive
care was in accordance with institutional guidelines. presynaptic terminals was determined by confocal microscopy and
computer-aided image analysis as described (Masliah et al., 1992a,
Excitotoxic Injury Model 1992b). F4/80-labeled sections were imaged with an Olympus UTV-
Kainic acid (KA) crosses the blood-brain barrier and induces excito- 1X digital camera mounted on an Olympus BX-60 microscope. The
toxic CNS injury, particularly in the hippocampus and the neocortex percent cortical area covered by F4/80 labeling in six microscopic
(Schauwecker and Steward, 1997). KA (Sigma) was dissolved in PBS fields (10
 objective) in four to six sections per brain was quantified
using the Bioquant 98 software (R&M Biometrics).and injected intraperitoneally in one dose at 15 mg/kg (mice on NIH/
For calbindin quantification, digitized images of immunostainedOla or NIH/Ola 
 Balb/c mixed background) or 25 mg/kg (C57BL/
sections were obtained with a video camera mounted on a Zeiss6J mice). Seizure activity was scored from 0 to 5, with 0 showing
microscope at a final magnification of 300
 and then analyzed withno behavioral changes and 5 showing constant rearing and falling
the Quantimet 570C system. For each mouse, two sagittal sectionsas described (Schauwecker and Steward, 1997). All KA-injected
(300 m apart) were selected, and from each section a total of tenmice reached at least stage 3. Control mice were injected with PBS.
random fields (0.16 mm2) in neocortical cell layers 2–3 and 4–5 wereMice were killed 24 hr after the injection, except for microtubule-
analyzed. The total number of positive cells per layer was averagedassociated protein 2 (MAP-2) and synaptophysin immunolabeling
and expressed as relative numbers per mm2.experiments, for which mice were killed 5 days after injection.
TUNEL LabelingTissue Preparation
DNA fragmentation, a hallmark of apoptosis, was detected by inMice were anesthetized with 400 mg/kg chloral hydrate (Sigma) and
situ labeling with the terminal deoxynucleotidyltransferase-medi-flush perfused transcardially with 0.9% saline. Brains were removed
ated UTP end labeling (TUNEL) assay kit (Roche). Briefly, six to nine
and snap-frozen in isopentane for extraction of RNA or embedded
cryosections per brain were fixed in 4% PFA for 20 min, permeabil-
in Tissue-Tek OCT compound (Sakura) and cut into 12 m thick
ized with 0.1% Triton X-100, acetylated for 10 min, dehydrated
sections with a cryostat. For some experiments, hemibrains cut through ethanol series, incubated with digoxygenin-labeled dUTP
sagitally were immersion fixed in freshly prepared phosphate-buf- and deoxynucleotidyl transferase at 37C for 1 hr, and labeled with a
fered 4% paraformaldehyde (PFA) (pH 7.4) at 4C for 48 hr and cut FITC- or Rhodamin-conjugated anti-digoxygenin antibody (Roche).
into 40 m thick sections with a vibratome (Leica) or sunk through TUNEL-positive cells were viewed and counted by fluorescence
30% sucrose in PBS and cut into 30 m thick sections with a cryo- microscopy. For double labeling, sections were either stained post-
tome (Leica). For most histological analyses, mice were perfused TUNEL with NeuroTrace following the manufacturer’s directions
with saline, then with PFA, and postfixed for 48 hr in PFA. Fixed (Molecular Probes, 1:200) or coincubated with NeuN or neurofila-
brains were embedded in paraffin and cut into 6 m thick sections. ment antibodies as described and detected with Alexa 647-conju-
gated secondary antibodies (Molecular Probes, 1:200).
Histochemistry
For hematoxylin and eosin staining, sections were deparaffinized, Activated Caspase Labeling
washed in water, stained in Mayer’s hematoxylin solution (Sigma) Activated caspases were detected with the fluorescently labeled
peptidic inhibitor CaspACE FITC-VAD-FMK (Promega), whichfor 15 min, washed in water, placed in 80% ethanol for 2 min,
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crosses the plasma membrane and binds to all activated caspases Statistical Analysis
Differences between two means were assessed by Mann-Whitneyin the cell. Cryosections were thawed, pretreated with 0.1% Triton
X-100 (Sigma) in TBST for 20 min, washed 3 
 5 min in TBST, and U or Student’s t test for nonparametric or parametric data, respec-
tively. Differences among multiple means of data with parametricincubated with CaspACE FITC-VAD-FMK (20 M) for 1 hr in the
dark. They were then washed 5 
 5 min in TBST and fixed in 4% distribution were assessed by ANOVA followed by Tukey-Kramer
post hoc test. All statistical analyses were done using the StatviewPFA for 30 min, washed 5 
 5 min in TBST, quickly rinsed in dH2O,
and mounted with Vectashield (Vector). Caspase-positive cells were software (SAS Institute).
viewed and counted by fluorescence microscopy by an observer
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